Owners, management and financials
CVR: 25230515
Previous names: ROCHE A/S. MEDICINALVARER & KEMIKALIER
DKK 928,824,000
Revenue
Net result: DKK 31,319,000
Roche Holding AG (100%)
CVR · view owners
Carole Hassoun
Board: Isabel Marianne Joerin (chair) and 2 members
CVR · view management
Active
Founded 21 January 1970
CVR · view overview
120 employees
CVR · 2018
Director role ended: Maria Falkenberg Petersen
CVR · 01/07/2025
View the full event history
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 120 employees (2018). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.
Source: annual report 2025, Danish Business Authority
Roche Pharmaceuticals A/S demonstrates a positive financial trajectory, with revenue increasing from 732.8 million DKK in 2021 to 928.8 million DKK in 2025. Profitability has also improved, rising from 16.3 million DKK in 2021 to 31.3 million DKK in 2025, indicating effective cost management and operational efficiency. The company's equity has strengthened significantly, growing from 143.5 million DKK in 2021 to 195.2 million DKK in 2025, reflecting a solid financial foundation. However, the absence of gross profit data limits a comprehensive analysis of margins. Overall, Roche Pharmaceuticals A/S is well-positioned in the pharmaceutical wholesale industry, showcasing robust growth and financial stability.
AI-generated summary · Generated 05/07/2026
Selskabets formål er a) Fabrikation, køb, salg og ind- og udførsel af og agenturvirksomhed for kemiske, farmaceutiske, medicinske, bioelektroniske, diagnostiske instrumenter og hjælpemidler. b) Videnskabelig forskning, udvikling, bearbejdning og afprøvelse af de under a) nævnte produkter. c) optagelse af enhver form for virksomhed, som i videste forstand direkte eller indirekte kan tjene til fremme af den ovennævnte formål, herunder, efter forudgående tilladelse fra relevante myndigheder, deltagelse i eller køb af kapitalandele i virksomheder, som har beslægtet formål, eller som kan fremme de ovennævnte formål.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 928.8 mio. | 31.3 mio. | 442.7 mio. | 195.2 mio. | 97 | |
| 202401/01/2024 – 31/12/2024 | 827 mio. | 24.3 mio. | 355.3 mio. | 163.9 mio. | 96 | |
| 202301/01/2023 – 31/12/2023 | 761.4 mio. | 36.5 mio. | 357.6 mio. | 139.6 mio. | 97 | |
| 202201/01/2022 – 31/12/2022 | 785.6 mio. | 19.6 mio. | 389.7 mio. | 163 mio. | 103 | |
| 202101/01/2021 – 31/12/2021 | 732.8 mio. | 16.3 mio. | 354.5 mio. | 143.5 mio. | 110 | |
| 202001/01/2020 – 31/12/2020 | 701.9 mio. | 12.3 mio. | 378.4 mio. | 127.2 mio. | 121 | |
| 201901/01/2019 – 31/12/2019 | 718.2 mio. | 21.8 mio. | 351.8 mio. | 159.9 mio. | 121 | |
| 201801/01/2018 – 31/12/2018 | 808.2 mio. | 30.2 mio. | 323.6 mio. | 138.2 mio. | 120 | |
| 201701/01/2017 – 31/12/2017 | 897.9 mio. | 33.1 mio. | 361.3 mio. | 158 mio. | 122 | |
| 201601/01/2016 – 31/12/2016 | 869.9 mio. | 25.5 mio. | 311.6 mio. | 124.9 mio. | 125 | |
| 201501/01/2015 – 31/12/2015 | 893.7 mio. | 29.2 mio. | 315.6 mio. | 129.4 mio. | 111 | |
| 201401/01/2014 – 31/12/2014 | 839.9 mio. | 26.7 mio. | 333.1 mio. | 100.2 mio. | 103 | |
| 201301/01/2013 – 31/12/2013 | 689.8 mio. | 14.5 mio. | 302.8 mio. | 88.6 mio. | 103 |
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
27 public tenders won
Showing 10 of 27 contracts
See all won contracts on UdbudsScannerSources: TED (the EU tender database) and udbud.dk
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of Roche Pharmaceuticals A/S is 25230515.
Roche Pharmaceuticals A/S is owned by Roche Holding AG.
The management of Roche Pharmaceuticals A/S consists of Carole Hassoun.
The board of Roche Pharmaceuticals A/S consists of Isabel Marianne Joerin, Carole Hassoun and Ehab Abdelmoneim Youssef Hassan, with Isabel Marianne Joerin as chair.
In 2025, Roche Pharmaceuticals A/S reported revenue of DKK 928,824,000.
Roche Pharmaceuticals A/S had 120 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Roche Pharmaceuticals A/S has published its annual report for 2025. Revenue came to DKK 928,824,000, and the net result was DKK 31,319,000.
Contact info changed: new phone: 36399999 (July 3, 2026).
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.162.b" issued by Amgros I/S worth 733,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.163.a" issued by Amgros I/S worth 136,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1057.a" issued by Amgros I/S worth 63,899,999 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.353.b" issued by Amgros I/S worth 2,321,995,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1482.b" issued by Amgros I/S worth 1,057,200,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1182.a" issued by Amgros I/S worth 241,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Rammeaftale om køb af Itovebi (inavolisib)" issued by Amgros I/S worth 38,500,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.202.a" issued by Amgros I/S worth 24,041,983 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.165.a" issued by Amgros I/S worth 1,566,600,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.167.b" issued by Amgros I/S worth 596,800,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1050.a" issued by Amgros I/S worth 169,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1053.b" issued by Amgros I/S worth 948,600,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1054.a" issued by Amgros I/S worth 593,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1042.b" issued by Amgros I/S worth 337,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.1461.a" issued by Amgros I/S worth 462,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Rammeaftale om køb af Evrysdi® (risdiplam)" issued by Amgros I/S worth 350,000,000 DKK.
Roche Pharmaceuticals A/S has published its annual report for 2024. Revenue came to DKK 826,964,000, and the net result was DKK 24,277,000.
As of July 1, 2025, Carole Hassoun has joined the board of directors of Roche Pharmaceuticals A/S.
As of July 1, 2025, Maria Falkenberg Petersen has left the board of directors of Roche Pharmaceuticals A/S.
As of July 1, 2025, Carole Hassoun is registered as adm. dir. of Roche Pharmaceuticals A/S.
As of July 1, 2025, Maria Falkenberg Petersen has stepped down as adm. dir. of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.1153.a" issued by Amgros I/S worth 890,400,000 DKK.
As of April 14, 2025, Maria Falkenberg Petersen is registered as adm. dir. of Roche Pharmaceuticals A/S.
As of April 14, 2025, Darine Ghanem has stepped down as adm. dir. of Roche Pharmaceuticals A/S.
As of April 8, 2025, Maria Falkenberg Petersen has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 8, 2025, Darine Ghanem has left the board of directors of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.164.a" issued by Amgros I/S worth 1,344,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 2.703.b" issued by Amgros I/S worth 183,298,522 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.180.a" issued by Amgros I/S worth 69,160,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.175.a" issued by Amgros I/S worth 666,000,000 DKK.
Roche Pharmaceuticals A/S has published its annual report for 2023. Revenue came to DKK 761,417,000, and the net result was DKK 36,536,000.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.976.a" issued by Amgros I/S worth 15,470,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.167.a" issued by Amgros I/S worth 291,550,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.352.b" issued by Amgros I/S worth 243,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.176.a" issued by Amgros I/S worth 157,309,680 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.169.b" issued by Amgros I/S worth 544,600,000 DKK.
Roche Pharmaceuticals A/S has published its annual report for 2022. Revenue came to DKK 785,584,000, and the net result was DKK 19,560,000.
As of November 1, 2022, Isabel Marianne Joerin has joined the board of directors of Roche Pharmaceuticals A/S.
As of November 1, 2022, Beat Christoph Krähenmann has left the board of directors of Roche Pharmaceuticals A/S.
On October 28, 2022, the company changed its name from ROCHE A/S. MEDICINALVARER & KEMIKALIER to Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2021. Revenue came to DKK 732,832,000, and the net result was DKK 16,253,000.
As of October 1, 2021, Darine Ghanem has joined the board of directors of Roche Pharmaceuticals A/S.
As of September 30, 2021, Richard John Wright has left the board of directors of Roche Pharmaceuticals A/S.
As of September 1, 2021, Darine Ghanem is registered as adm. dir. of Roche Pharmaceuticals A/S.
As of August 31, 2021, Richard John Wright has stepped down as director of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2020. Revenue came to DKK 701,850,000, and the net result was DKK 12,300,000.
Roche Pharmaceuticals A/S has published its annual report for 2019. Revenue came to DKK 718,237,000, and the net result was DKK 21,755,000.
As of October 31, 2019, Ehab Abdelmoneim Youssef Hassan has joined the board of directors of Roche Pharmaceuticals A/S.
As of October 31, 2019, Luc Jozef Leon Dirckx has left the board of directors of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2018. Revenue came to DKK 808,154,000, and the net result was DKK 30,177,000.
As of April 29, 2019, Beat Christoph Krähenmann has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 29, 2019, Michael Egede Budtz has left the board of directors of Roche Pharmaceuticals A/S.
As of April 28, 2019, Beat Christoph Krähenmann has left the board of directors of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2017. Revenue came to DKK 897,912,000, and the net result was DKK 33,122,000.
As of August 28, 2017, Richard John Wright has joined the board of directors of Roche Pharmaceuticals A/S.
As of August 28, 2017, Ronald Jeyung Park has left the board of directors of Roche Pharmaceuticals A/S.
As of August 1, 2017, Richard John Wright is registered as director of Roche Pharmaceuticals A/S.
As of August 1, 2017, Linda Valentin Vestergaard has stepped down as director of Roche Pharmaceuticals A/S.
As of June 1, 2017, Linda Valentin Vestergaard is registered as director of Roche Pharmaceuticals A/S.
As of June 1, 2017, Ronald Jeyung Park has stepped down as director of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2016. Revenue came to DKK 869,907,000, and the net result was DKK 25,476,000.
Roche Pharmaceuticals A/S has published its annual report for 2015. Revenue came to DKK 893,694,000, and the net result was DKK 29,179,000.
Roche Pharmaceuticals A/S has published its annual report for 2014. Revenue came to DKK 839,936,000, and the net result was DKK 26,654,000.
As of February 11, 2015, is registered as an owner of Roche Pharmaceuticals A/S with an ownership share of 100%.
Roche Pharmaceuticals A/S has published its annual report for 2013. Revenue came to DKK 689,754,000, and the net result was DKK 14,505,000.
As of May 6, 2014, KPMG P/S has been appointed auditor of Roche Pharmaceuticals A/S.
As of May 6, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Roche Pharmaceuticals A/S.
As of May 6, 2014, Ronald Jeyung Park has joined the board of directors of Roche Pharmaceuticals A/S.
As of May 6, 2014, Ronald Jeyung Park is registered as director of Roche Pharmaceuticals A/S.
As of May 6, 2014, Luc Jozef Leon Dirckx has stepped down as director of Roche Pharmaceuticals A/S.
As of April 1, 2014, Janet Friedman Makepeace has left the board of directors of Roche Pharmaceuticals A/S.
As of April 1, 2014, Luc Jozef Leon Dirckx is registered as director of Roche Pharmaceuticals A/S.
As of April 1, 2014, Janet Friedman Makepeace has stepped down as director of Roche Pharmaceuticals A/S.
As of March 17, 2014, Beat Christoph Krähenmann has joined the board of directors of Roche Pharmaceuticals A/S.
As of March 17, 2014, Jennifer Elizabeth Cook has left the board of directors of Roche Pharmaceuticals A/S.
As of September 1, 2013, Jennifer Elizabeth Cook has joined the board of directors of Roche Pharmaceuticals A/S.
As of September 1, 2013, Peter Hug has left the board of directors of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2012.
As of May 9, 2012, Janet Friedman Makepeace has joined the board of directors of Roche Pharmaceuticals A/S.
As of May 9, 2012, Janet Friedman Makepeace has joined the board of directors of Roche Pharmaceuticals A/S.
As of May 9, 2012, Janet Friedman Makepeace has left the board of directors of Roche Pharmaceuticals A/S.
As of May 9, 2012, Robin Stephen Turner has left the board of directors of Roche Pharmaceuticals A/S.
As of May 9, 2012, Janet Friedman Makepeace is registered as director of Roche Pharmaceuticals A/S.
As of May 9, 2012, Janet Friedman Makepeace is registered as director of Roche Pharmaceuticals A/S.
As of May 9, 2012, Janet Friedman Makepeace has stepped down as director of Roche Pharmaceuticals A/S.
As of May 9, 2012, Robin Stephen Turner has stepped down as director of Roche Pharmaceuticals A/S.
As of January 12, 2012, Luc Jozef Leon Dirckx has joined the board of directors of Roche Pharmaceuticals A/S.
As of May 9, 2008, EY Godkendt Revisionspartnerselskab has been appointed auditor of Roche Pharmaceuticals A/S.
As of May 9, 2008, CJ Partnership I/S has stepped down as auditor of Roche Pharmaceuticals A/S.
As of May 2, 2007, Peter Hug has joined the board of directors of Roche Pharmaceuticals A/S.
As of May 2, 2007, Claude Georges Charles Schreiner has left the board of directors of Roche Pharmaceuticals A/S.
As of March 30, 2006, Robin Stephen Turner has joined the board of directors of Roche Pharmaceuticals A/S.
As of March 30, 2006, Daniel Patrick O'Day has left the board of directors of Roche Pharmaceuticals A/S.
As of March 30, 2006, Robin Stephen Turner is registered as director of Roche Pharmaceuticals A/S.
As of March 30, 2006, Daniel Patrick O'Day has stepped down as director of Roche Pharmaceuticals A/S.
As of April 22, 2004, CJ Partnership I/S has been appointed auditor of Roche Pharmaceuticals A/S.
As of April 22, 2004, A/S PSE NR. 4820 has stepped down as auditor of Roche Pharmaceuticals A/S.
As of April 3, 2003, Daniel Patrick O'Day has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 3, 2003, Rudolf Fischer has left the board of directors of Roche Pharmaceuticals A/S.
As of April 1, 2003, Daniel Patrick O'Day is registered as director of Roche Pharmaceuticals A/S.
As of April 1, 2003, Rudolf Fischer has stepped down as director of Roche Pharmaceuticals A/S.
As of April 18, 2001, Michael Egede Budtz has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 18, 2001, Claude Georges Charles Schreiner has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 18, 2001, Ole Brøns has left the board of directors of Roche Pharmaceuticals A/S.
As of April 18, 2001, William Murray Burns has left the board of directors of Roche Pharmaceuticals A/S.
As of March 24, 1999, William Murray Burns has joined the board of directors of Roche Pharmaceuticals A/S.
As of March 24, 1999, Andreas Friedrich Leuenberger has left the board of directors of Roche Pharmaceuticals A/S.
As of March 5, 1998, Ole Nørregaard has left the board of directors of Roche Pharmaceuticals A/S.
As of March 5, 1998, Otto August Meile has left the board of directors of Roche Pharmaceuticals A/S.
As of April 1, 1996, Rudolf Fischer has joined the board of directors of Roche Pharmaceuticals A/S.
As of April 1, 1996, Jean-Willy Tanner has left the board of directors of Roche Pharmaceuticals A/S.
As of April 1, 1996, Rudolf Fischer is registered as director of Roche Pharmaceuticals A/S.
As of April 1, 1996, Jean-Willy Tanner has stepped down as director of Roche Pharmaceuticals A/S.
As of June 21, 1995, Armin Maximilian Kessler has left the board of directors of Roche Pharmaceuticals A/S.
As of November 29, 1991, Ernst Peter Krebs has left the board of directors of Roche Pharmaceuticals A/S.
As of November 29, 1991, Ernst Peter Krebs has stepped down as director of Roche Pharmaceuticals A/S.
As of October 4, 1990, Markus Christoph Altwegg has left the board of directors of Roche Pharmaceuticals A/S.
As of June 3, 1990, CJ Partnership I/S has stepped down as auditor of Roche Pharmaceuticals A/S.
As of November 4, 1988, Walter Alwin Werner has left the board of directors of Roche Pharmaceuticals A/S.
As of November 4, 1988, Walter Alwin Werner has stepped down as director of Roche Pharmaceuticals A/S.
As of January 21, 1970, A/S PSE NR. 4820 has been appointed auditor of Roche Pharmaceuticals A/S.
As of January 21, 1970, CJ Partnership I/S has been appointed auditor of Roche Pharmaceuticals A/S.
As of January 21, 1970, Ole Nørregaard has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Ole Brøns has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Walter Alwin Werner has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Ernst Peter Krebs has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Jean-Willy Tanner has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Andreas Friedrich Leuenberger has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Markus Christoph Altwegg has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Armin Maximilian Kessler has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Otto August Meile has joined the board of directors of Roche Pharmaceuticals A/S.
As of January 21, 1970, Walter Alwin Werner is registered as director of Roche Pharmaceuticals A/S.
As of January 21, 1970, Ernst Peter Krebs is registered as director of Roche Pharmaceuticals A/S.
As of January 21, 1970, Jean-Willy Tanner is registered as director of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S was founded on January 21, 1970.
Companies in the same industry and area
CVR 43707795
CVR 35818790
CVR 33597037
CVR 40486585
CVR 34352542
